Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
CALL
AeroVironment
AVAV
$8.14B
| $1.67M | ﹤0.01% |
10,100
+8,200
| +432% | +$1.47M |
|
1852
CALL
TG Therapeutics
TGTX
$8.31B
| $1.66M | ﹤0.01% |
30,300
+10,600
| +54% | +$434K |
|
1853
PUT
HP
HPQ
$27.2B
| $1.66M | ﹤0.01% |
+75,700
| New | +$1.67M |
|
1854
Centene
CNC
$32.1B
| $1.66M | ﹤0.01% |
25,872
-424,094
| -94% | -$22.7M |
|
1855
NXP Semiconductors
NXPI
$56.9B
| $1.66M | ﹤0.01% |
5,890
+2,124
| +56% | +$585K |
|
1856
CALL
Cytokinetics
CYTK
$10.7B
| $1.65M | ﹤0.01% |
19,400
-86,200
| -82% | -$6.19M |
|
1857
Intuit
INTU
$100B
| $1.65M | ﹤0.01% |
6,326
-197,002
| -97% | -$68.6M |
|
1858
Simon Property Group
SPG
$70.6B
| $1.65M | ﹤0.01% |
7,356
+341
| +5% | +$70.2K |
|
1859
Albany International
AIN
$1.68B
| $1.64M | ﹤0.01% |
22,062
-25,564
| -54% | -$1.6M |
|
|
MNTN
1860
MNTN Inc
MNTN
$965M
| $1.64M | ﹤0.01% |
178,624
-31,611
| -15% | -$288K |
|
|
GLXY
1861
CALL
Galaxy Digital Inc
GLXY
$4.59B
| $1.64M | ﹤0.01% |
+60,100
| New | +$1.67M |
|
1862
PUT
Adobe
ADBE
$109B
| $1.64M | ﹤0.01% |
8,000
+6,800
| +567% | +$1.61M |
|
1863
SI-BONE Inc
SIBN
$895M
| $1.64M | ﹤0.01% |
+100,364
| New | +$1.43M |
|
1864
Avis
CAR
$5.18B
| $1.64M | ﹤0.01% |
11,070
+4,242
| +62% | +$934K |
|
1865
Corsair Gaming
CRSR
$1.18B
| $1.63M | ﹤0.01% |
+168,755
| New | +$1.31M |
|
1866
Nu Holdings
NU
$70.4B
| $1.63M | ﹤0.01% |
122,033
-1,835,100
| -94% | -$24.7M |
|
1867
Li Auto
LI
$12.8B
| $1.63M | ﹤0.01% |
138,561
+126,365
| +1,036% | +$2.07M |
|
1868
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.63B
| $1.63M | ﹤0.01% |
+15,200
| New | +$1.78M |
|
1869
PUT
iShares MSCI Germany ETF
EWG
$1.72B
| $1.62M | ﹤0.01% |
+39,200
| New | +$1.65M |
|
1870
KKR & Co
KKR
$97.4B
| $1.62M | ﹤0.01% |
17,638
-2,906,476
| -99% | -$282M |
|
|
VSNT
1871
Versant Media Group
VSNT
$5.39B
| $1.62M | ﹤0.01% |
44,869
-67,976
| -60% | -$2.73M |
|
1872
Design Therapeutics
DSGN
$938M
| $1.61M | ﹤0.01% |
+111,103
| New | +$1.39M |
|
1873
Janus International
JBI
$697M
| $1.61M | ﹤0.01% |
289,656
+117,999
| +69% | +$619K |
|
1874
Rush Enterprises Class A
RUSHA
$8.54B
| $1.6M | ﹤0.01% |
21,903
-208,007
| -90% | -$14.7M |
|
1875
IHS Holding
IHS
$2.84B
| $1.6M | ﹤0.01% |
193,984
+12,703
| +7% | +$105K |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.